The vaccine yields fewer antibodies against the variant discovered in South Africa, and so the company plans to test an alternate version.The vaccine yields fewer antibodies against the variant discovered in South Africa, and so the company plans to test an alternate version.Coronavirus (2019-nCoV), your-feed-science, Moderna Inc, Vaccination and Immunization, United States, South AfricaRead More
